Digital Pathology: Technologies and Global Markets

Report Code: HLC161E

Publish Date: Apr 2025

Publisher: BCC Publishing

Category: Health Maintenance

Download Report Overview

Limited Period Offer

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global digital pathology market is expected to grow from $7.8 billion in 2024 and is projected to reach $13.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.9% during the forecast period of 2024 to 2029.

Report Includes

  • 91 data tables and 57 additional tables
  • An analysis of the global market for digital pathology technologies
  • Analyses of global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
  • Descriptions of the upcoming market opportunities for the digital pathology market, factors driving its growth, and forecasts for this market’s segments and sub-segments
  • Estimates of the market size and forecasts for the digital pathology market in value (USD millions) terms, and a corresponding market share analysis by system, type, application, end user and geographic region
  • In-depth information regarding major market dynamics, technology updates, new products and applications, and COVID-19’s impact on the market for digital pathology
  • Coverage of the technological, economic, and business considerations of the global market for digital pathology, with analyses and market forecasts through 2029
  • Information on mergers and acquisitions, agreements, collaborations and product launches in the digital pathology industry
  • Analysis of relevant patents
  • A discussion of the industry’s ESG challenges and practices
  • Analysis of the competitive landscape for digital pathology companies, and a value share analysis based on their segmental revenues and financial performance
  • Profiles of the leading global companies, including F. Hoffmann-La Roche Ltd., 3DHISTECH Ltd., Nikon Instruments Inc., Danaher Corp., and Indica Labs Inc.

Report Scope

This report analyzes the digital pathology market, providing forecasted trends and sales projections for this market through 2029. It covers key market players, product segments, supporting technologies, emerging trends, competitive intelligence, major geographies and their competitive landscapes, and it offers regional insights. The report’s in-depth analysis of market dynamics and their impact(s) forms the foundation for its qualitative assessments and market estimates.

Digital pathology is the process of converting glass slide samples into digital images to enable electronic analysis, storage and sharing. This conversion, which enhances diagnostic accuracy, collaboration and efficiency by facilitating advanced imaging, computational analysis and telepathology, has revolutionized pathology with data-driven insights and remote consultations.

While this report outlines the conventional processes of pathology laboratories, it does not include market analysis for traditional lab devices such as microscopes and slides. The connectivity and network issues discussed are specific to data and information related to pathology lab diagnoses, excluding broader hospital-based mHealth (Mobile Health) concerns. This report’s coverage of telepathology is focused on diagnostic applications, research and development (R&D), and education and training but does not address telemedicine at a broader level.

This report addresses regulatory aspects, including innovations; technological advances (patents and approvals); and the latest trends, preferences and developments in digital pathology. As part of its analysis, it segments the digital pathology market by system, type, application and end user. The market has also been segmented into the following major geographies, North America, Asia-Pacific, Europe and the Rest of the World, and there is focused coverage of countries such as the U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea and China.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $7.0 Billion
Market size forecast $13.7 Billion
Growth rate CAGR of 11.9% for the forecast period of 2024-2029
Units considered $ Millions
Segments covered System, Type, Application, End User, and Region
Regions covered North America, Asia-Pacific, Europe, Rest of the World
Countries covered U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, China, South Korea, Australia, South America, and Middle East and Africa
Key Market Drivers
  • Cost-effectiveness driving expansion.
  • Growing adoption of digital pathology to enhance lab efficiency.
  • Increasing incidence of cancer.
  • Increasing investments and funding in digital pathology.
Companies studied
3DHISTECH LTD.APOLLO ENTERPRISE IMAGING CORP.
CLINISYS INC.CORISTA
F. HOFFMANN-LA ROCHE LTD.FUJIFILM HOLDINGS CORP.
HURON TECHNOLOGIES INTERNATIONAL INC.INDICA LABS LLC.
KONINKLIJKE PHILIPS N.V.LEICA BIOSYSTEMS NUSSLOCH GMBH
LIGOLAB INFORMATION SYSTEMS MIKROSCAN TECHNOLOGIES INC.
NIKON INSTRUMENTS INC.VISIOPHARM A/S
XIFIN INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global market for digital pathology was $7.0 billion 2023. The market is expected to grow at a compound annual growth rate (CAGR) of 11.9%, reaching about $13.7 billion by 2029.
  • Cost-effectiveness drives expansion.
  • Rising Adoption of digital pathology to enhance lab efficiency.
  • Increasing incidence of cancer.
  • Increasing investments and funding in digital pathology.
The market has been segmented based on system, product type, application, end-user, and geography.
  • Based on the system, the market in this report is segmented into Digital In Vitro Diagnostic (IVD) devices, digital pathology (DP) devices, digital pathology analytics, digital communication platforms, digital pathology storage platforms, and telepathology systems. Digital IVD devices are further segmented into automated hematology analyzers, blood cell counters, digital holographic microscopy, digital urine sediment analyzers, digital chromosome analyzers, immunohistochemistry image analysis, digital PCR, FISH enumeration systems, digital cytopathology, and signet cell detection. DP devices are further segmented as scanners, robotic microscopes, and digital cameras.
  • Based on type, the market in this report is segmented into digital hematology and clinical pathology, digital anatomical pathology, digital microbiology, digital genetic pathology, digital immunopathology, digital chemical pathology, and digital forensic pathology to enhance precision diagnostics.
  • Based on application, the digital pathology market is segmented into disease diagnosis, drug discovery, drug development, and R&D.
  • Based on end users, the market is segmented as hospitals, diagnostic centers, biotech and pharma companies, and academic centers.
  • This report also covers the regional market analysis of digital pathology. The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, and the Rest of the world. The regional segment will cover a detailed analysis of major countries such as the U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea and China.
Digital IVD devices will dominate the market by the end of 2029.
North America holds the highest share in the market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Digital Pathology: Technologies and Global Markets170Free
Chapter- 1: Executive Summary4Free
Chapter- 2: Market Overview5Free
Chapter- 3: Market Dynamics12Free
Chapter- 4: Regulatory Landscape4Free
Chapter- 5: Market Segmentation Analysis77Free
Chapter- 6: Emerging Trends and Technologies6Free
Chapter- 7: ESG Developments5Free
Chapter- 8: Patent Analysis3Free
Chapter- 9: Competitive Landscape8Free
Chapter- 10: Appendix46Free
Published - Dec-2022| Analyst - BCC Publishing| Code - HLC161D

Report Highlights

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

Report Includes

  • 52 data tables and 32 additional tables
  • An up-to-date overview and analysis of the global markets for digital pathology technologies
  • Analyses of the global market trends, with historic market revenue data for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the upcoming market opportunities for the digital pathology market, industry specific growth driving factors, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of the actual market size and market forecast for digital pathology in value (USD millions) terms, and their corresponding market share analysis by system, type, application, end-user, and geographic region
  • In-depth information (facts and figures) concerning major market dynamics, technology updates, new products and applications, and COVID-19 impact on the market for digital pathology
  • Coverage of the technological, economic, and business considerations of the global market for digital pathology, with analyses and market forecasts through 2027
  • Updated information on key mergers and acquisition deals, agreements, collaborations and product launches within the digital pathology industry
  • A relevant patent analysis
  • Analysis of the company competitive landscape for digital pathology market, and company value share analysis based on segmental revenues and key financial performance
  • Profile descriptions of the leading global companies, including CliniSys, F. Hoffmann-La Roche Ltd., Leica Biosystems Inc., Nikon Instruments Inc., and XIFIN Inc.
Published - Oct-2019| Analyst - Bhavna Joshi| Code - HLC161C

Report Highlights

The global digital pathology market should reach $10.2 billion by 2023 from $4.8 billion in 2018 at a compound annual growth rate (CAGR) of 16.5% for the period of 2018 to 2023.

Report Includes

  • 52 data tables and 44 additional tables
  • An overview of the global digital pathology market
  • Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Information on key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence, and geographic trends
  • Opportunities and major factors driving and inhibiting growth of the global labware market and its subsegments
  • Discussion on various supply chain members such as manufacturers, suppliers, service providers and diagnostic centers
  • Patent analysis covering significant patent allotments
  • Profiles of key companies, product portfolios, strategies and recent developments, including 3DHISTECH, Huron Technologies International Inc., Mikroscan Technologies Inc., Nikon Instruments Inc., Visiopharm and Ventana Medical Systems Inc.
Published - Feb-2016| Analyst - Bhavna Joshi| Code - HLC161B

Report Highlights

The global digital pathology market will grow from nearly $3.2 billion in 2015 to nearly $6.5 billion by 2020 with a compound annual growth rate (CAGR) of 15.0% for the period of 2015-2020.

Report Includes

  • An overview of the global digital pathology market.
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
  • Key factors that impact market growth by subsegments and geography and to analyze trends and opportunities in major regions, including North America, Europe, Asia and the rest of the world (ROW).
  • Information on key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence, and geographic trends.
  • Opportunities and major factors driving and inhibiting growth of the global labware market and its subsegments.
  • Discussion on various supply chain members such as manufacturers, suppliers, service providers and diagnostic centres.
  • Profiles of key companies, product portfolios, strategies and recent developments.

Published - Feb-2014| Analyst - Bhavna Joshi| Code - HLC161A

Report Highlights

The global digital pathology market totaled nearly $2.1 billion in 2012. This market is expected to grow at a compound annual growth rate (CAGR) of 14.7% from $2.2 billion in 2013 to nearly $4.5 billion in 2018.

Report Includes

  • An overview of the global digital pathology market.
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Information on key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence, and geographic trends.
  • Discussion on various supply chain members such as manufacturers, suppliers, service providers and diagnostic centres.

 

Related Reports

Global Markets for Emerging Medical Device Technologies

Published - Mar 2025 | Publisher - Partha Sarathi Das | Code - HLC191C

The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.

Microscopy: The Global Market

Published - Dec 2024 | Publisher - BCC Publishing | Code - IAS017H

The global market for microscopy is expected to grow from $9.7 billion in 2024 and is projected to reach $13.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.6% during the forecast period of 2024 to 2029.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Global Markets for Telemedicine Technologies

Published - Sep 2022 | Publisher - BCC Publishing | Code - HLC014L

The global market for telemedicine technologies is estimated to increase from $72.4 billion in 2022 to reach $173.3 billion by 2027, with a compound annual growth rate (CAGR) of 19.1% from 2022 through 2027.

Recent Reports

Digital Pathology: Technologies and Global Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - HLC161E

The global digital pathology market is expected to grow from $7.8 billion in 2024 and is projected to reach $13.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.9% during the forecast period of 2024 to 2029.

Medical Aesthetic Devices: Technologies and Global Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - HLC056E

The global market for medical aesthetic devices was valued at $20.1 billion in 2023. It is projected to grow from $22.2 billion in 2024 to $37.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.3% from 2024 through 2029.

Global Markets for Emerging Medical Device Technologies

Published - Mar 2025 | Publisher - Partha Sarathi Das | Code - HLC191C

The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.

Clinical Trial Infrastructure Regional Analysis Market: Middle East and North Africa

Published - Mar 2025 | Publisher - Kunal Nagpure | Code - HLC304A

This report provides an overview of the clinical trial infrastructure markets in the Middle East and North Africa (MENA) region. It includes a detailed examination of the market dynamics and an understanding of the MENA clinical trial landscape by study status, phase, type, results and sponsor type.

Intravenous (IV) Therapy and Vein Access: Global Markets

Published - Mar 2025 | Publisher - BCC Publishing | Code - HLC046F

The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.

Top Trending Reports

Carbon Capture, Utilization & Storage Technologies

Published - Feb 2025 | Publisher - BCC Publishing | Code - EGY037G

The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.

Global Diabetic Care Devices Market

Published - Feb 2025 | Publisher - BCC Publishing | Code - MDS019B

The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.

2024 Semiconductor Manufacturing Research Review

Published - Mar 2025 | Publisher - BCC Publishing | Code - SMC086G

This 2024 Research Review of the Semiconductor Manufacturing provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions.

Generative AI: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - IFT308A

The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.

2024 Medical Devices Research Review

Published - Mar 2025 | Publisher - BCC Publishing | Code - MDS060B

The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Digital Pathology: Technologies and Global Markets
Sample Report